Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-09

Clinical Trial Update: Carnitine Supplementation and Skeletal Muscle Function [Phase 3]

View source ↗

Summary

Phase 3 clinical trial on carnitine supplementation for skeletal muscle function in sarcopenia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Gdansk University of Physical Education and Sport | Conditions: Sarcopenia | Phase 3 | Status: COMPLETED | Results posted: 2019-05-09